source
- Gilead places partial clinical hold on two KITE-753 CAR-T trials in diffuse large B-cell lymphomaGilead announced on its third-quarter earnings call that it has placed a partial clinical hold on two CAR-T trials for KITE-753 targeting diffuse large B-cell lymphoma (DLBCL). The hold affects th…
- Genetic Testing Helps Refine Kidney Disease Trial Design, Says Natera ExpertIn a sponsored episode of The Top Line, Dr. Ronen Schneider, Natera's medical director of renal genetics, explains how genotype‑defined kidney disease data can improve clinical trial design. He not…